Laboratory-acquired Gambian trypanosomiasis.
Receveur MC, LeBras M, Vincendeau P.
N Engl J Med. 1993 Jul 15;329(3):209-10. doi: 10.1056/NEJM199307153290317.
Gambian human African trypanosomiasis in North West Uganda. Are we on course for the 2020 target?
Selby R, Wamboga C, Erphas O, Mugenyi A, Jamonneau V, Waiswa C, Torr SJ, Lehane M.
PLoS Negl Trop Dis. 2019 Aug 14;13(8):e0007550. doi: 10.1371/journal.pntd.0007550. eCollection 2019 Aug.
Pentamidine: a review.
Sands M, Kron MA, Brown RB.
Rev Infect Dis. 1985 Sep-Oct;7(5):625-34. doi: 10.1093/clinids/7.5.625.
Chronic Gambian trypanosomiasis.
Robinson B, Clark RM, King JF, Hurt B, Mohr JA.
South Med J. 1980 Apr;73(4):516-8. doi: 10.1097/00007611-198004000-00032.
Coagulation studies in Gambian trypanosomiasis.
Greenwood BM, Whittle HC.
Am J Trop Med Hyg. 1976 May;25(3):390-4. doi: 10.4269/ajtmh.1976.25.390.
Immunosuppression in Gambian trypanosomiasis.
Greenwood BM, Whittle HC, Molyneux DH.
Trans R Soc Trop Med Hyg. 1973;67(6):846-50. doi: 10.1016/0035-9203(73)90013-8.
Short-course eflornithine in Gambian trypanosomiasis: a multicentre randomized controlled trial.
Pépin J, Khonde N, Maiso F, Doua F, Jaffar S, Ngampo S, Mpia B, Mbulamberi D, Kuzoe F.
Bull World Health Organ. 2000;78(11):1284-95.
Recent developments in human African trypanosomiasis.
Welburn SC, Odiit M.
Curr Opin Infect Dis. 2002 Oct;15(5):477-84. doi: 10.1097/00001432-200210000-00004.
The epidemiology and control of human African trypanosomiasis.
Pépin J, Méda HA.
Adv Parasitol. 2001;49:71-132. doi: 10.1016/s0065-308x(01)49038-5.
The treatment of Gambian trypanosomiasis.
MILLER JK.
New Orleans Med Surg J. 1947 Feb;99(8):386-96.
